Pages that link to "Q15424759"
Jump to navigation
Jump to search
The following pages link to selexipag (Q15424759):
Displaying 21 items.
- Prostaglandin I2 receptor (Q905736) (← links)
- pulmonary hypertension (Q1128595) (← links)
- Uptravi (Q29006621) (← links)
- A thorough QT study in the context of an uptitration regimen with selexipag, a selective oral prostacyclin receptor agonist (Q34775420) (← links)
- Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag (Q35673848) (← links)
- Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects (Q36125460) (← links)
- Selexipag for the treatment of pulmonary arterial hypertension (Q38176060) (← links)
- Multiple-dose up-titration study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of selexipag, an orally available selective prostacyclin receptor agonist, in healthy subjects (Q39119790) (← links)
- Selexipag for the Treatment of Pulmonary Arterial Hypertension (Q51562704) (← links)
- Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension (Q51741466) (← links)
- A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery (Q62054264) (← links)
- A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects (Q63400029) (← links)
- Bioequivalence of different dose-strength tablets of selexipag, a selective prostacyclin receptor agonist, in a multiple-dose up-titration study (Q85551382) (← links)
- A Study of Selexipag in Healthy Male Participant (Q86292020) (← links)
- Selexipag for the treatment of pulmonary arterial hypertension (Q86698959) (← links)
- A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging (Q97045160) (← links)
- A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study (Q102153511) (← links)
- Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension (Q113920841) (← links)
- Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease (Q113921091) (← links)
- User:DeltaBot/fixClaims/maintenance/P715format (← links | edit)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)